Fiscal year 2020 neurofibromatosis research program support services.
Ended Awarded Last action
- Contract number
- W81XWH20F0377
- Awardee
-
Leidos, Inc. UEI QLNMVC12KWY3 Part of Leidos Holdings, Inc.
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $224,378
Award facts
- Opportunity
-
- W81XWH17R0036 Solicitation number
- Meeting, Scientific and Administrative Support Services (MSASS), Request for Proposal (RFP) Award Notice · Posted Apr 12, 2017
- Meeting, Scientific and Administrative Support Services Award Notice · Posted Mar 22, 2017
- Contract value 70% obligated
-
- $224,378.05 Current, with exercised options
- $320,279.55 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Two Step
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $3,100 | |
| Funding Only Action | -$53,002 | |
| Funding Only Action | -$46,000 | |
| Exercise an Option | $184,377 | |
| Original award | $135,903 |
About this award
The Defense Health Agency issued a delivery order to Leidos, Inc. on August 28, 2020, with a ceiling value of $320,279.55 for Fiscal Year 2020 Neurofibromatosis Research Program support services under a cost-plus-fixed-fee pricing structure.
Place of performance is Frederick, Maryland. The order was completed on August 27, 2022. Per Section 711 of the 2019 National Defense Authorization Act, the U.S. Army Medical Research and Materiel Command (under which this work was originally funded) transferred to the Defense Health Agency on October 1, 2022, with a corresponding funding modification applied to this delivery order. No set-aside was used.
Quick answers
Who was awarded contract W81XWH20F0377?
W81XWH20F0377 was awarded to Leidos, Inc. by Medical Command (Department of the Army) on August 28, 2020.
How much is contract W81XWH20F0377 worth?
The government has obligated $224,378 on W81XWH20F0377. Its potential value, with all options, is $320,280.
Which agency awarded contract W81XWH20F0377?
Medical Command (Department of the Army) awarded W81XWH20F0377, with funding from Defense Health Agency (Department of Defense).
Is contract W81XWH20F0377 an order under another contract?
Yes. W81XWH20F0377 is a delivery order under W81XWH17D0025, an indefinite delivery contract.
Was contract W81XWH20F0377 competed?
The extent of competition for W81XWH20F0377 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award